Maraviroc Tablet, Film Coated
Product Images NDC 68475-007
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Maraviroc (NDC 68475-007). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Navinta Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Pdp-150mg (9623d31f 0856 4aca A288 C542b28edfba 02)
This text contains information about tablets called Maraviroc, each containing 150 mg of the active ingredient. It provides storage instructions, dosage information, and details about manufacturing in India for N Navinta LLC. It also mentions the expiration date, warning not to use if the safety seal is missing, and the necessity to dispense in tight containers. The tablets should be stored between 20°C and 25°C, with excursions permitted between 15°C and 30°C. It indicates the need to refer to the prescribing information for dosage details and to always dispense with a medication guide. Additionally, the text includes a code number, NDC number (68475-008-01), and the quantity of tablets in the package (60 tablets Rx only).*
Pdp-300mg (9623d31f 0856 4aca A288 C542b28edfba 03)
This text is a medication label for Maraviroc Tablets containing 300 mg each. It includes information on storage conditions (between 20°C and 25°C), warnings about the safety seal under the cap, dispensing instructions, dosage information, manufacturer details (Navinta LLC in Ewing, NJ), and a unique Code No. The medication is made in India. It is recommended to dispense with a medication guide. *
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.